Date lodged: 17 April 2019
To ask the Scottish Government what protocols are in place to ensure that the correct procedures are followed when treating people with mucopolysaccharidosis (MPS) who are at risk of allergic reactions, including those who have recorded an antibody build up during enzyme replacement therapy.
Answered by: Jeane Freeman 9 May 2019
There are established guidelines for identification and reduction of allergic reactions throughout Medical services to minimise risk. Protocols include seeking a history of allergy before medical interventions at risk of producing an allergy.